51 employees
MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.
2005
$6M
from 3 investors over 3 rounds
MolecularMD raised $6M on April 2, 2012
Investors: Ballast Point Ventures and Nextech Invest
MolecularMD raised $3M on January 30, 2009
Investors: Ballast Point Ventures